Griffin Asset Management, Inc. Guardant Health, Inc. Transaction History

Griffin Asset Management, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$28.82 - $77.35 $95,768 - $257,034	-3,323 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$88.71 - $120.43 $16,322 - $22,159	-184 Reduced 5.25%	3,323 $332,000
Q3 2021 Nov 05, 2021	SELL	$98.77 - $132.17 $31,705 - $42,426	-321 Reduced 8.39%	3,507 $438,000
Q1 2021 May 04, 2021	SELL	$127.04 - $179.1 $95,280 - $134,325	-750 Reduced 16.38%	3,828 $584,000
Q4 2020 Jan 27, 2021	BUY	$99.96 - $135.93 $4,098 - $5,573	41 Added 0.9%	4,578 $590,000
Q3 2020 Nov 12, 2020	SELL	$80.32 - $111.8 $190,358 - $264,966	-2,370 Reduced 34.31%	4,537 $507,000
Q2 2020 Aug 18, 2020	SELL	$60.49 - $97.5 $43,794 - $70,590	-724 Reduced 9.49%	6,907 $560,000
Q1 2020 May 18, 2020	BUY	$59.04 - $88.81 $4,132 - $6,216	70 Added 0.93%	7,631 $531,000
Q4 2019 Feb 11, 2020	SELL	$59.49 - $82.78 $11,898 - $16,556	-200 Reduced 2.58%	7,561 $591,000
Q3 2019 Nov 05, 2019	SELL	$62.59 - $110.3 $223,759 - $394,322	-3,575 Reduced 31.54%	7,761 $495,000
Q2 2019 Aug 19, 2019	BUY	$63.94 - $91.11 $9,846 - $14,030	154 Added 1.38%	11,336 $979,000
Q1 2019 May 08, 2019	BUY	$34.3 - $97.98 $383,542 - $1.1 Million	11,182 New	11,182 $858,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.24B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Griffin Asset Management, Inc. with notifications on news.